Chief Executive Officer and Director

Chief Strategy Officer (CSO)

Fennec Pharmaceuticals Brief: Says Achieved Second Quarter 2025 Total Net Revenues of US$9.7 Million

Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update

Fennec Pharmaceuticals trading halted, volatility trading pause

Fennec Pharmaceuticals trading resumes

Executive Administrative Assistant

Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing PEDMARK® to reduce the risk of platinum-induced ototoxicity in pediatric patients. The Executive Assistant will support the CEO and Senior Leadership Team by managing calendars, coordinating travel, and organizing meetings while exercising discretion and independent judgment.

Sign up with Google

Sign in with Google